Molluscum contagiosum arising in melanocytic nevus and in superficial spreading melanoma

Journal of Cutaneous Pathology

Volumn 36, Issue 4, 2009, Pages 461-463

  Dobrosavljevic, Danijela ^a   Brasanac, Dimitrije ^a   Lukic, Silvana ^b   Dzodic, Radan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Department of Pathology   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

HSV 1716; ONCOLYTIC VIRUS;

ADULT; ARTICLE; CANCER CELL DESTRUCTION; CANCER REGRESSION; CASE REPORT; EPILUMINESCENCE MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MELANOMA CELL; MOLLUSCIPOXVIRUS; MOLLUSCUM CONTAGIOSUM; NEWCASTLE DISEASE PARAMYXOVIRUS; ONCOLYTIC VIROTHERAPY; PARAMYXOVIRUS; RECOMBINANT DNA TECHNOLOGY; REPLICON; SUPERFICIAL SPREADING MELANOMA; VACCINIA VIRUS;

ADULT; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOLLUSCUM CONTAGIOSUM; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 61449102708     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01039.x     Document Type: Article

References (13)

1. Murphy FA, Fauquet CM, Bishop DHL, et al. Virus taxonomy. Classification and nomenclature of viruses. Arch Virol Suppl 1995 10 : 1.
2. Senkevich TG, Koonin EV, Bugert JJ, Dara G, Moss B. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology 1997 233 : 19.
3. Cribier B, Scrivener Y, Grosshans E. Molluscum contagiosum: histologic patterns and associated lesions. A study of 578 cases. Am J Dermatopathol 2001 23 : 99.
4. Marks JG, White JW. Molluscum contagiosum in a halo nevus. Int J Dermatol 1980 19 : 258.
5. Konya J, Thompson CH. Molluscum contagiosum virus: antibody responses in persons with clinical lesions and seroepidemiology in a representative Australian population. J Infect Dis 1999 179 : 701.
6. Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. J Clin Oncol 2002 20 : 2220.
7. Vähä-Koskela MJV, Kallio JP, Jansson LC, et al. Oncolytic capacity of attenuated replicative Semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice. Cancer Res 2006 66 : 7185.
8. Greiner S, Humrich JY, Thuman P, Sauter B, Schuler G, Jenne L. The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity. Clin Exp Immunol 2006 146 : 344.
9. Nettelbeck DM, Rivera AA, Balagué C, Alemany R, Curiel DT. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter. Cancer Res 2002 62 : 4663.
10. Aghi M, Martuza RL. Oncolytic viral therapies - the clinical experience. Oncogene 2005 24 : 7802.
11. Batliwalla FM, Bateman BA, Serrano D, et al. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. Mol Med 1998 4 : 783.
12. Mastrangello MJ, Maguire HC Jr., Eisenlohr LC, et al. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Ther 1999 6 : 409.
13. MacKie RM, Stewart B, Brown SM. Intralesional injection of herpes simplex virus 1716 in metastatic melanoma. Lancet 2001 357 : 525.